Reyon Pharmaceutical Co (XKRX:102460) Days Sales Outstanding : 96.88 (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Reyon Pharmaceutical Co Days Sales Outstanding?

Reyon Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ₩39,300 Mil. Reyon Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ₩37,015 Mil. Hence, Reyon Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 96.88.

The historical rank and industry rank for Reyon Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

XKRX:102460' s Days Sales Outstanding Range Over the Past 10 Years
Min: 93.27 Med: 140.87 Max: 166.91
Current: 93.27

During the past 13 years, Reyon Pharmaceutical Co's highest Days Sales Outstanding was 166.91. The lowest was 93.27. And the median was 140.87.

XKRX:102460's Days Sales Outstanding is ranked worse than
68.74% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs XKRX:102460: 93.27

Reyon Pharmaceutical Co's Days Sales Outstanding declined from Mar. 2023 (98.25) to Mar. 2024 (96.88).

Reyon Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Reyon Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reyon Pharmaceutical Co Days Sales Outstanding Chart

Reyon Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

129.55

118.48

102.77

97.48

98.74

Reyon Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															98.25	91.27	93.17	92.55	96.88

Competitive Comparison of Reyon Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Reyon Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Reyon Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Reyon Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Reyon Pharmaceutical Co's Days Sales Outstanding falls into.

Reyon Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Reyon Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (41809.744	+	39926.56)	/	2 )	/	151071.144	*	365
=	40868.152					/	151071.144	*	365
=	98.74

Reyon Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (39926.56	+	38673.553)	/	2 )	/	37014.673	*	365 / 4
=	39300.0565					/	37014.673	*	365 / 4
=	96.88

Reyon Pharmaceutical Co (XKRX:102460) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Reyon Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Reyon Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Reyon Pharmaceutical Co (XKRX:102460) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Reyon Pharmaceutical Co Ltd (XKRX:102460) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

416, Yeongdong-daero, 8th floor, Gangnam-gu, Seoul, KOR

Website

http://reyonpharm.co.kr

Reyon Pharmaceutical Co Ltd is a Korea-based pharmaceutical company. It is engaged in the manufacturing and distribution of specialty medicines and raw materials. The main business of the company has been divided into generic drugs, original drugs, and drug substances The key products include eye drops, injection, antibiotics, skeletal muscle relaxants, coagulation drugs, anti-inflammatory enzymes, and blood vessels dialectic drugs, among others.

Reyon Pharmaceutical Co (XKRX:102460) Headlines

No Headlines